NCT04750928 2026-04-01Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical NeurofibromasNational Institutes of Health Clinical Center (CC)Phase 1/2 Recruiting55 enrolled